CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
$20.10
arrow_upward
+0.67%(+0.13) 1D
Okt 16, 9:38:58 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CHGCY...
Buksan
$19.33
Mataas
$20.14
Mababa
$19.33
Mkt. cap
10.67T
Avg. na dami
335.66K
Dami
47.50K
Mataas nang 52-wk
$34.84
Mababa nang 52-wk
$18.33
Beta
0.56
Mga natitirang share
3.36B
Bilang ng mga empleyado
5K
Buksan
$19.33
Mataas
$20.14
Mababa
$19.33
Mkt. cap
10.67T
Avg. na dami
335.66K
Dami
47.50K
Mataas nang 52-wk
$34.84
Mababa nang 52-wk
$18.33
Beta
0.56
Mga natitirang share
3.36B
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
5 oras ang nakalipas
UBS keeps Hold on Chugai Pharmaceutical stock at JPY 6,700 target
ad-hoc-news.de
·
7 oras ang nakalipas
Chugai Pharmaceutical stock pre-market at EUR 35.84
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Tungkol sa Chugai Pharmaceutical ADR